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Abstract:
Naturally occurring small molecules (metabolites, signaling intermediates) are a
critical component of the information flow in biology, along with DNA, RNA, and
proteins. Metabolomics is an analytical approach that seeks to comprehensively analyze
naturally occurring small molecules and quantify their dynamic changes in biological
systems. In recent years metabolomics has begun to provide understanding of the
metabolic basis of different diseases, such as heart disease, cancer, and diabetes.
Our lab built a High-Performance Liquid-Chromatography Mass-Spectrometry
(HPLC-MS) based metabolomics platform to analyze metabolites from mammalian cells,
spent cellular media, and model organisms such as C. elegans. We used C. elegans to
elucidate the metabolic changes seen after treatment with Metformin, which is a known
activator of the AMPK pathway.
Cancer cells exhibit high levels of glycolysis producing large amounts of lactate;
circumventing the mitochondrial pathway. This phenomenon is known as the Warburg
effect. We hypothesize that cancer metabolism is epigenetically regulated. Epigenetics
refers to inheritable traits that are not due to alterations in the primary DNA sequence.
DNA methylation is an important epigenetic modification. DNA methylation mainly
occurs in the CpG islands of the promoter region of genes. It is believed that during
cancer development de novo DNA methyltransferases methylate tumor-suppressing genes
allowing cancer cells to proliferate uninhibited. There are two de novo DNMTs,
DNMT3A, and DNMT3B. These DNMTs establish the pattern of methylation. We
examined de novo DNMT-mediated control of cellular metabolism, identifying global
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changes in metabolism, as well as differential sensitivity towards glycolytic and
mitochondrial inhibitors.
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Chapter 1: Developing an HPLC-MS based metabolomics platform to
characterize metabolism In Vitro
Introduction:
Metabolomics is an emerging field of study that seeks to systematically identify and
quantify naturally occurring small molecules in a complex biological system. The field of
metabolomics compliments the other “omic” fields such as proteomics, transcriptomics, and
genomics. The central dogma of biology states DNA is transcribed into RNA, and then RNA is
translated into proteins. Cellular biochemicals are a central component of biology, and mediate
the flow of information in the central dogma. Cellular metabolites are biochemicals with low
molecular weight (<1,800Da) including lipids, amino acids, peptides, nucleic acids, organic
acids, vitamins, thiols, and carbohydrates. The analysis of these naturally occurring biochemical
allows the metabolic status of a biological system to be defined (Zhou et al., 2012). Metabolism
is a complex process that can be broken into two complementary reactions, anabolism and
catabolism. Anabolism is the synthesis of large molecules from smaller molecules, and
catabolism is the breakdown of large molecules into smaller molecules. Metabolism is a systemic
reaction occurring in every tissue and cell of an organism all of the time. Metabolomics has two
different but complementary analytical of approach-targeted and untargeted. When approaching
metabolomics in a targeted fashion identification and quantification of specific metabolites or
metabolite classes in a particular pathway is the focus of study. A targeted approach is therefore
hypothesis driven. An untargeted approach seeks to identify all metabolites in a biological
system, this approach is generally used to further develop a hypothesis, an untargeted approach is
more discovery based. Metabolomics is currently being developed to identify biomarkers; in
response to environmental stress, drug discovery, comparing mutants, toxicology, nutrition,
studying global effects of genetic manipulation, cancer, comparing different growth stages,
1

diabetes and natural product discovery (Zhang et al., 2012a). The range of chemical properties of
these different small molecules is diverse and therefore requires the appropriate separation
technique to analyze metabolites.
A wide variety of analytical approaches must be employed in metabolomics analysis.
There are multiple highly validated instruments used to study metabolism. Of the different
instruments available that are accepted to produce high quality, reproducible results include but
are not limited to NMR, MS, GC-MS, HPLC-MS, CE-MS, and UPLC-MS. These methods will
briefly be discussed.
Nuclear Magnetic Resonance (NMR) uses the magnetic properties of certain nuclei
creating magnetic dipole and quadrapole moments (Kleckner and Foster, 2011). NMR is one of
the most common spectroscopic analytical techniques because it has the ability to identify and
quantify a wide range of organic metabolites. NMR-based metabolomics provides a real-time
analysis of metabolites allowing one biological sample to be used in a time course without
disrupting the sample itself. However, NMR has a relatively low sensitivity threshold when
measuring metabolites, making it an inadequate method for measuring low-abundance
metabolites (Zhang et al., 2012a).
Mass Spectrometry (MS) is a method of analyzing metabolites that can either be
performed on its own, or coupled with another analytical technique such as chromatography. MS
has gained prominence because of its high sensitivity, and wide range of detectable metabolites.
MS has also proven to be reliable, reproducible, and high-throughput (Lei et al., 2011). A mass
spectrometer is comprised of three main parts; ion source, mass analyzer, and detector. The ion
source first converts sample molecules into ions, depending on the mass analyzer, ions are either
resolved in a time-of-flight tube or in an electromagnetic field, then metabolites are measured by
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the detector (Zhou et al., 2012). Direct injection is not an ideal method to examine complex
mixtures and identifying individual metabolite peaks because of the possibility of ion
suppression and the matrix effect (Gosetti et al., 2010), however MS fingerprinting is still a
useful tool in examining patterns of metabolites. Fingerprinting is also useful when trying to
distinguish between two different physiological states (Allen et al., 2003).
For higher resolution of metabolites a common practice has been to couple MS with
chromatography. Gas Chromatography (GC) is a common analytical technique used in plant
metabolomics. GC provides an ideal profiling approach to analyzing polar and non-polar
metabolites, especially lipid metabolites. Polar metabolites are derivatised to render them
volatile. If a metabolite is not volatile it cannot be detected by GC. Polar metabolites require
derivitization at a functional group such as hydroxyl (-OH), sulfhydryl (-SH), and carboxyl (COOH), etc. This is to reduce polarity, and increase thermal stability and volatility (Dettmer et
al., 2007; Zhang et al., 2012a). Common derivitization methods include alkylation, acylation and
silylation. Alkylation reagents reduce the polarity of the compounds by substituting aliphatic or
aliphatic-aromatic group for labile hydrogens. Acylation removes the labile hydrogens and
transforms the compound into an ester, thioester, and amides. These two methods require a
purification step before analyses on the GC (Schummer et al., 2009). Silylation is another
common derivatization method in which the labile hydrogens from acids, alcohols, thiols,
amines, amides or enolizable ketones and aldehydes are replaced by a trimethylsilyl group, this
reaction occurs via nucleophilic attack (SN2). Common silylation reagents are N, O-bis(trimethylsilyl)trifluoroacetamide (BSTFA), and N-methyl-trimethylsilyltrifluoroacetamide
(MSTFA) (Schummer et al., 2009). The advantage of using GC is typically that it can be coupled
to a single quadrupole instrument and uses Electron Ionization (EI). The advantages of an EI are
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a low influence of molecular structure on response, and a large number of characteristic
fragments. The disadvantage is the derivitization process and the necessity of metabolites to have
labile hydrogens that can undergo derivatization (Alder et al., 2006).
Capillary Electrophoresis (CE) is a method of separation. CE separates analytes with high
resolution based on their migration through a liquid filled capillary column in an electric field.
Capillary Electrophoresis-Mass Spectrometry (CE-MS) is a favorable method of identifying
polar or ionic compounds found in biological samples, including urine, blood, and saliva. CEMS is also used to analyze inorganic ions, organic acids, amino acids, nucleotides and
nucleosides, vitamins, thiols, carbohydrates, and peptides (Metzger et al., 2009; Zhang et al.,
2012a). A disadvantage of CE-MS is that in order to achieve unidirectional movement of
analytes the electrophoretic separation must be done in an electric field. This makes it difficult to
couple CE to the ion source of an MS. Decreasing the electric field is possible, however this
action reduces efficiency and resolution (Heiger, 2000).
A method that has been extensively developed for metabolomics analysis is high
performance liquid chromatography coupled to mass spectrometry (HPLC-MS). HPLC-MS
separates metabolites through a column in one of two ways, isocratic or gradient elution.
Isocratic elution uses a water-solvent composition that remains constant during the metabolite
separation. Isocratic elution is common when a sample contains approximately 10 metabolites.
The other method is a gradient elution, which uses a gradient of solvents over a time course,
based upon the composition of the buffers, metabolites with similar chemical properties will
elute. Gradient elution creates narrow metabolite peaks, and faster analysis (Zhou et al., 2012).
HPLC-MS allows semi-polar and polar metabolites to be identified. The spectrum of chemical
properties observed in metabolomics prevents any one column from identifying all metabolites,
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therefore a variety of columns and chemistries must be employed. Hydrophilic Interaction Liquid
Chromatography (HILIC) is the ideal method for separating amino sugars, amino acids,
vitamins, carboxylic acids and nucleotides (Buszewski and Noga, 2012; Xiao et al., 2012).
HILIC also compliments Reverse Phase LC (RPLC), allowing compounds that are not
sufficiently retained under RPLC conditions to be resolved by giving an opposing elution of
metabolites to that of RPLC. Normal-Phase LC (NPLC) can also separate polar compounds,
however NPLC is more compatible with APCI-MS instead of ESI-MS. HILIC can use any polar
stationary phase. A commonly used stationary phase is an amino-propyl stationary phase (Xiao
et al., 2012). The mobile phase consists of a mixture of water-water miscible organic solvents,
usually acetonitrile. Starting with a high percentage of organic solvent non-polar metabolites are
able to elute from the column. Gradually increasing water or aqueous content allows polar
metabolite elution from the column (Greco and Letzel, 2013). HILIC is different from both
normal phase, and reverse phase LC with characteristics of both methods.
Our lab specifically uses an Agilent HPLC, which directly injects samples into an Agilent
6520 Accurate Mass Quadrupole Time-Of-Flight (TOF) System. This system has a mass
accuracy of 0.001 amu. Since metabolites of interest have an average mass of ~1,000 Da
identifying metabolites using this system reduces the possibility of formulae. In Figure 1 the
orange bar denotes the mass accuracy of this system. Metabolites of interest are typically <1,000
Da which means that an identified metabolite has approximately 10 possible chemical formulae.
This prevents the necessity of fragmenting large quantities of standards to eliminate potential
formulae of metabolites.
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Materials and Methods:
Extracellular Metabolite Extraction:
1 ml of culture medium was collected from each sample for extracellular metabolite
extraction. Samples were centrifuged for 10 minutes at 15,000 x g and at 4°C to remove cell
debris. If samples were not processed immediately, they were placed at -80°C. 400 µL of sample
was placed in a glass vial containing 400 µL of 100% MeOH +0.1% Agilent Mix (AM). AM is a
mixture of two known metabolites with distinct peaks and abundances. Solvents are spiked with
a known concentration, when samples are run on the MS we use these peaks to ensure the
abundance is equal across all samples, as well as ensuring the retention time is the same. This
ensures the HPLC is running properly. Non-polar metabolites were extracted by adding 800 µL
of CHCl3 was spiked with 0.1% fatty acid standard. The samples were centrifuged at 3,000 x g
for 10 minutes. Forming two distinct layers, separated by a thin white film, this is debris that has
6

precipitated out and will not be further analyzed. The top layer, MeOH, contains the polar
metabolites. The lower organic layer, CHCl3 contains the non-polar lipid metabolites which were
removed using a glass pasture pipette and dried using liquid nitrogen (LN2). The polar
metabolites in MeOH were dried down using a SpeedVac. Polar metabolites were reconstituted
in 100 µL of 50% MeOH and nonpolar metabolites were reconstituted in 100 µL of CHCl3,
before being run on the HPLC-MS. Any remaining sample was placed at -80°C.
Intracellular Metabolite Extraction:
Cells were washed twice with cold 1X PBS in order to remove any residual media or
extracellular components and then lysed using 400 µL 50% MeOH + 0.1% A.M. when plated in
a 6-well dish. The cells were scraped and collected into a 9ml glass separation vial. Samples
were centrifuged at 3,000 x g for 10 minutes at 4°C, forming two distinct layers. The top layer
contains the polar metabolites. The lower organic layer contains the non-polar lipid metabolites.
The lower organic layer was removed and dried using LN2, and the polar metabolites, in MeOH,
were dried down using a SpeedVac. Polar metabolites were reconstituted in 100 µL of 50%
MeOH, and the nonpolar metabolites were recinstituted in 100 µL of CHCl3. Remaining samples
were stored at -80°C.
Extracellular MS Fingerprinting:
Spent media was used to detect extracellular metabolites. The samples were then diluted
ten-fold. Aliquot 5µl of media and combine that with 50µl of 30% MeOH+0.1% ammonium
hydroxide. Samples were then centrifuged at 8,000 x g for 5 minutes at 4°C. 30µl of sample was
then transferred to an auto-sampling vial and directly injected into the MS.

7

High Performance Liquid Chromatography-Mass Spectrometry:
Performance of LC-MS was accomplished using an Agilent 1200 series HPLC system
and a G6520 accurate mass Q-TOF high resolution mass spectrometer. Data was acquired from
10μl injections of each sample employing a 35 minute gradient at a flow rate of 0.3ml/minute. A
HILIC gradient was employed, which includes two solvents: A. 20 mM Ammonium Acetate
(NH4OAc) + 5% Acetonitrile (ACN) and B. ACN. Solvent gradients are listed in Table 1. Total
time per HPLC run is 47 minutes.

The conditions of the column include: a Luna amino propyl (NH2) column (150 x 2.0 mm
3μm) held at 20°C, purchased from Phenomenex. Data was acquired over a mass range of 1001100 Daltons in negative ion mode, and data analysis was conducted using Agilent MassHunter
version B.04.00 and Mass Profiler Professional version B.12.
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Results and Discussion

The method of extraction first designed in our lab was taken directly from the Rabinowitz
lab at Princeton University. At this lab, extractions using varied solvents, and varying amounts
were performed. A method of combining acetonitrile/ methanol/ water (40:40:20) with their
samples and then placing this mixture at -20°C for 15 minutes, removing the supernatant, and
adding additional solvent to re-extract metabolites was described (Rabinowitz and Kimball,
2007). When using this method of extraction we were able to detect a range of metabolites;
however the life of the HPLC column was short-lived. The extraction method above was causing
large molecules to clog the separation column and guard column. Figure 2 shows a small
sampling of metabolites from different metabolic pathways that were detected after extracting
neural stem cells. Due to the premature decline of the column, we went back into the literature
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and discovered an alternative method of extraction, employing a 1:1:3 H2O; MeOH; CHCl3
mixture (Sana and Fischer, 2009). After performing the two extraction methods side by side, we
are able to identify more metabolites using chloroform in the extraction.

After determining the chloroform method was more advantageous in terms of quantities
of identified metabolites, and less error among biological replicates optimization trials of
multiple parameters was conducted. To ensure no artificial peaks were being detected
optimization trial solidified the notion that plastic is highly incompatible with chloroform. Figure
3 shows the comparison of two Total Ion Chromatograms (TIC); the extractions were performed
side by side of two control samples of neural stem cells. Sample conditions were consistent, the
only variable was plastic or glass consumable products. The green line denotes samples that were
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extracted using glass vials, and glass pasture pipettes, where the black line represents that
extraction performed using autoclaved microcentrifuge tubes, and autoclaved plastic pipette tips.

Use of plastics with chloroform can indeed cause artificial peaks to appear. After data
analysis a heat map of various unidentified mass spectral features shows large variation between
glass consumables and plastic consumables. Figure 4 is a heat map of unidentified mass spectral
features that are either up or down-regulated. The only experimental condition that was different
was the use of glass or plastic. This leads us to believe that chloroform is allowing plasticizer
molecules to leach into the samples causing these contaminating peaks. All steps that include the
use of chloroform are performed in glassware only, as to prevent these artificial peaks. OSHA
guidelines, regarding the storage and use of chloroform, clearly states “Do not use rubber or
plastic hose or pipe to transfer chloroform” (Administration). leading us to believe the best
11

approach would be to use chloroform in glassware, preventing the chloroform from leaching
plastics into samples, and the HPLC/MS.
Conclusions:
Developing a method necessitates intense literature searches. All aspects starting from
sample preparation to conducting statistical analysis of metabolites after data analysis is
completed is a time-consuming process. Once an analytical technique has been developed, and
metabolites can successfully be identified, samples from a wide range of biological applications
can be examined. This is not to say that once a satisfactory method has been developed no other
methods should be examined. Therefore, as different methods become available they may be
viewed as alternatives.
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Chapter 2: Caenorhabditis elegans- a model organism to examine the
interaction between ahr-1 and Metformin.
Introduction:
The Aryl Hydrocarbon Receptor (AHR) pathway is known for its importance in
development, and its role in dioxin mediated cytotoxicity.(Nebert et al., 2000) AHR is a basic
helix-loop-helix (bHLH) and Per-Arnt-Sim containing transcription factor that is liganddependent (Nguyen and Bradfield, 2008) .Figure 5 shows these different domains in murine
model, the Ala375 position has been identified as a polymorphism that is responsible for ligand
affinity. When Ala375→Val375 ligand affinity is greatly reduced.

AHR has many high affinity ligands including a wide variety of ubiquitous and
hydrophobic environmental contaminants such as halogenated aromatic hydrocarbons (HAHs)
and non-halogenated polycyclic aromatic hydrocarbons (PAHs). The most well characterized
HAHs is 2, 3, 7, 8-tetrachlorodibenzodioxin (TCDD) which is the most potent known agonist of
AHR (Denison et al., 2002). While AHR was discovered for its importance in dioxin binding, it
gained much interest when it was discovered to play a role normal physiology and development
(Zhang, 2011). In AHR null mice many developmental issues arose, the portcaval shunt in the
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developing liver failed to close immediately causing hepatovascular blood flow and altered
disposition of small molecules requiring hepatic clearance. Mice also experienced other vascular
issues including the persistence of the hyaloid artery and an altered limbal vasculature within the
developing eye. This led to the conclusion that AHR plays an important role in the regulation of
normal vascular or hematopoietic development (Nguyen and Bradfield, 2008). Mice carrying the
hypomorphic AHR allele experienced the same developmental issues. These mice could be
rescued by TCDD treatments. The ductus venosus closed properly after this activation, which
suggests this is an endogenous function of AHR (Zhang, 2011). Non-ligand bound AHR is
located in the cytoplasm in an inactive protein complex composed of a dimer of Heat Shock
Protein 90 (Hsp90), prostaglandin E synthase 3, and a single molecule of the immunophilin-like
protein hepatitis B virus X-associated protein 2 (XAP2). Figure 6 is a schematic representation
of a ligand binding to AHR. Upon ligand binding the XAP2 is released, then ligand bound AHR
translocates to the nucleus and dissociate from the remaining protein complex, exposing the PAS
domains, which allows the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT) to bind
AHR. This heterodimer complex then directly and indirectly interact with DNA by binding to the
5’ regulatory region of dioxin-responsive genes (Zhang, 2011). AHR has been referred to as an
“environmental sensor” because of its ability to bind to and metabolize environmental toxins
(Nguyen and Bradfield, 2008). Understanding cellular metabolism of environmental stimuli is
crucial in understanding how the environment alters gene transcription, metabolism, and other
physiological functions. Because the levels of metabolites can be regarded as the ultimate
response of biological systems to genetic or environmental changes, coupling it to
transcriptomics and proteomics allows for a more comprehensive understanding (Ma et al.,
2012).
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Caenorhabditis elegans (C. elegans) are free-living soil nematodes. C. elegans have a
defined lifespan of approximately 3 weeks, including a 3 day larval period. C. elegans were the
first multicellular organism to have their entire genome sequenced. Along with their
transparency, hermaphroditic nature C. elegans genetics are also easily manipulated via RNAi,
or creating gene knockout mutant strain (Frooninckx et al., 2012). All of these factors make C.
elegans powerful model organisms. AHR is conserved in C. elegans, the ortholog is termed ahr1, and the nuclear dimerization partner is encoded by aha-1. Ahr-1 and aha-1 has been directly
implicated in the differentiation of neurons, more specifically the AVM and SDQR. C. elegans
have a surprising resemblance as far as their nervous system is concerned to vertebrates
(Frooninckx et al., 2012). When ahr-1 is knocked down, strains showed reduced growth,
reproduction, and survival. Defects in other systems have also been reported including the liver,

15

heart, ovaries, and the vascular and immune system (Qin and Powell-Coffman, 2004). There are
multiple ahr-1 knock out worms ZG24 and CZ2485. The ZG24 strain is a deletion of 1165 base
pairs which includes multiple exons in the PAS domain. The CZ2485 strain is a substitution of
one nucleotide (c/t) (wild type/ mutant) causing a premature stop codon in the ahr-1 protein
(WormBase). C. elegans ahr-1 mutants are valuable in vivo models. Although there may be
differences between the mammalian and C. elegans ahr-1 ortholog certain similarities can shed
light on the mammalian counterparts. Determination of pathway interactions could allow for
further understanding regarding cross talk between different pathways of interest. The AMPK
pathway is another pathway that is conserved in C. elegans. Metformin, 1, 1-Dimethylbiguanide
hydrochloride has been shown to have a lifespan extending phenotype through activation of the
AMPK pathway. The AMPK pathway has been dubbed the energy sensing pathway, however
how it senses an environmental cue is still unknown. Determining the relationship between
Metformin, the AHR pathway and AMPK pathway may help understand how environmental
cues affect metabolism. Utilizing ahr-1 knockout worms and Metformin, we can examine cross
talk of AMPK-AHR pathways.
Materials and Methods:
Strains and Culturing:
The ahr-1 mutant strains - CZ2485 and ZG24 - were ordered from Caenorhabditis
Genetics Center (CGC). The Bristol N2 strain a kind gift from Dr. Gordon Lithgow (Buck
Institute) served as a control. Worms were cultivated and maintained on nematode growth
medium (NGM) plates with OP50 as a food source.
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Lifespan Assay:
For the first seven days of the lifespan the worms were placed on 5-fluorodeoxyuridine
(FUdR) (+) plates to prevent the eggs from hatching. The final concentration of FUdR is 10
µg/mL. Metformin (Sigma-Aldrich St. Louis, MO) was added at varying concentrations, 50 mM,
and 25 mM. 30-40 L4 worms were placed on each plate Worms are counted every 2-3 days
during the experiment; the dead worms are tallied. As the lifespan continues the worms will
begin to move less frequently. During lifespans, platinum wire should be used to gently prod the
worm on the head if the worm does not respond to the prod they are considered dead. Worms
were censored if they crawled off the plate, suffered from internal hatching, or protrusion of
gonads was observed. The lifespan data were plotted on a survival curve using Graphpad Prism
4.
Mass Cultures:
When mass culturing worms, OP50 must be concentrated. Place 25 g of Luria Broth (LB)
into a 2L flask. Add 1L of nanopure water, autoclave the solution, once the solution has cooled
inoculate the LB with 10µl of OP50. Allow the bacteria to grow for 16 hours. Once the cultures
become cloudy centrifuge at 3,000 RPM for 1 hour, remove the supernatant and resuspend the
bacteria, for every liter of bacteria ~15 ml of s-basal should be used.
When mass culturing worms, thousands of eggs must be harvested. To obtain this amount
of eggs in the same developmental stage, adult worms must be dissolved while keeping the eggs
intact. To hypo the worms wash a 10 cm plate with 3 ml of S-basal. Place the worms into a 15 ml
conical. Pellet the worms, than add 10 ml of a hypochlorite solution to the worms. The adult
carcasses should dissolve after vigorously shaking the conical for ~30 seconds. Once the adult
worms have completely dissolved the eggs should be washed 5 times with S-basal to ensure all
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the hypochlorite solution is removed. Eggs should be incubated in S-basal overnight to ensure all
eggs have hatched and have entered into the L1 stage of development. The L1 worms should be
counted and approximately 10,000 L1s should be placed on a 10 cm plate and incubated until
they have reached the L4 stage of development. Once the worms have reached the L4 stage they
are to be placed on Metformin + FUdR plates, or the control plates containing FUdR. After the
appropriate time has elapsed the worms should be collected. To collect the worms place 3 ml of
S-basal on the plate and swirl the plate to suspend the worms. Collect the worms into a 15 ml
conical; allow the worms to gravity settle for 10-15 minutes, than aspirate off access S-basal. To
snap freeze the worms until they are ready to be processed further place the conical in liquid
nitrogen until the entire pellet has frozen then immediately place the samples at -80°C.
Metabolite Extraction:
In a 50 ml glass centrifuge vial place the worm pellet, obtaining both the weight of the
glass vial, then the weight of the glass vial with the sample. Add 4 ml of ice cold 50% MeOH.
Maintain the worms on ice from this point. Subject the culture to 4- 1 minute sonication while on
ice. Add 8 ml of chloroform to each sample, vortex the samples vigorously for 30 seconds.
Allow the two layers to settle, slowly remove the top aqueous layer of MeOH containing the
polar metabolites. Once the aqueous layers have been removed add equal volumes 0.5M KCl/
0.08M H3PO4. Vortex the samples vigorously for an additional 30 seconds, now Place the
samples in an ultrasonic water bath for 15 minutes. Samples were vortexed twice in 1 minute
intervals. Centrifuge the samples for 2,000 x g for 10 minutes to separate the phases. Collect the
lower organic layer which contains non-polar metabolites. Samples were dried under nitrogen
until all chloroform has been removed.
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Results and Discussion
Lifespan of Wildtype N2 and ahr-1 Mutant Worm Treated with 50mM Metformin:

Lifespans of ahr-1 null worms in the presence and absence of Metformin were conducted
to determine if ahr-1 influenced Metformin mediated lifespan extension. Figure 7 shows the
lifespan of N2 wild-type worms treated with 50 mM Metformin, a dramatic increase in lifespan
is seen with the addition of Metformin. C. elegans not only experienced an overall extension, but
a median extension as well. During the lifespan assay not only was worm death taken into
account but worm health-span was also noted. (Data not shown) Metformin worms showed
increased mobility later in life, in contrast to respective control worms. Both ahr-1 mutant
worms showed a statistically significant increase in lifespan. Figure 8 is a lifespan comparing the
19

ahr-1 null Metformin treatment worms to the N2 Metformin treated worms no statistically
significant changes occurring.

The lifespan analysis of ahr-1 null worms compared to the wild-type worms showed no
median lifespan extension, or overall lifespan extension that was statistically significant. This
leads us to believe that Metformin is acting independently of the ahr-1 gene.
Metabolomics of Metformin Treated C. elegans:
Implementing our untargeted metabolomics based platform as discussed in Chapter 1, a
global analysis of polar and non-polar metabolites was conducted. Mass cultures of N2 worms
were grown on Metformin plates for 5 days. The goal of extracting metabolites after 5 days is to
determine the early metabolism changes that the worms experience while being exposed to 50
mM Metformin.
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Figure 9: is a subset of metabolites from an array of different pathways that were found to
be significantly altered upon Metformin treatment. From our initial screen of significantly altered
metabolites one pathway showed potential. The branched chain amino acid degradation pathway
(BCAA) showed three metabolites were significantly altered, leucine, isoleucine, and valine.
Further analysis of the BCAA degradation pathway is shown in Figure 10. Analysis of
intermediates in the BCAA degradation pathway showed slight increases and decreases, however
no additional significantly altered metabolites were identified.
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This pathway could be cooperating with other pathways in mediating Metformin
metabolism. Mutant strains lacking enzymes in the branched-chain amino acid pathway can shed
more light on the role BCAA’s play in Metformin mediated lifespan extension.
Conclusions:
Metformin is an important drug that is currently being used by millions of Americans to
combat type II diabetes. The mechanism of Metformin is not fully understood. Our first
hypothesis was ahr-1 was involved in the metabolism of Metformin. When conducting a lifespan
using the null worms no significant change was examined. The mechanism of Metformin may be
working through multiple pathways, with varied effects in many pathways. A global analysis of
all metabolites was conducted to determine if a certain pathway was up or down regulated. This
portion of research was not a main focus, therefore we have not completed data mining to
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determine if another pathway was significantly altered. Some prospective pathways include
NAD metabolism, serine degradation pathway, and tryptophan degradation pathway. Along with
mining the current data; future experiments could include more biological replicates, and
collection points.
Initially, this data lead us to believe the branched chain amino acid degradation pathway
could be the potential target. BCAA degradation pathway has been shown to be important in
glucose and insulin sensitivity in mice that were fed a high fat diet (Newgard et al., 2009). The
data that was collected suggests that the mechanism by which Metformin works could be the
BCAA degradation pathway in cooperation with other pathways.
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Chapter 3: DNA Methyltransferase Mediated Regulation of Cellular
Metabolism
Introduction:
Epigenetics is a term that refers to the reversible, inheritable trait (e.g. gene expression)
wherein the DNA sequence itself is not altered. DNA methylation is an example of epigenetic
modification that mainly occurs at the C5 position of cytosine (5mC) within a CpG island. CpG
islands are short regions of DNA ranging from 0.5-4kb in length that is often found in the
promoter regions of genes. The donor methyl group comes from S-Adenosyl methionine
(AdoMet). The process of DNA methylation as seen in Figure 5 is carried out by DNA
Methyltransferases (DNMTs). These enzymes catalyze the covalent addition of a methyl group
from AdoMet to the 5 position of the cytosine ring (Fukushige and Horii, 2013). DNA
methylation can be inhibited by the compound 5-azacytidine, which contains a nitrogen in the
cytosine ring at the 5 position. This forms a covalent bond between the 5-azacytidine and the
DNMT (Fukushige and Horii, 2013).
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Methylation of DNA plays an especially important role during early embryonic
development, stem cells differentiation, and tissue-specific gene expression (Yim et al., 2012).
However, DNA methylation also plays a significant role in the development of many different
forms of cancers (Liu et al., 2007; Yan et al., 2011). In tumor cells, unlike normal cells, a high
proportion of CpG islands are hypermethylated, thereby silencing specific genes, such as tumor
suppressing genes (TSG). Hypermethylation of the TSGs is one of the most well-categorized
epigenetic events in tumor formation (Jones and Baylin, 2002). For example, hypermethylation
of the promoter region of the BRCA1 gene has been shown to lead to breast cancer and
hypermethylation of STK11 genes have been linked to familial forms of renal, breast and colon
cancer (Jones and Baylin, 2002). Along with TSGs being hypermethylated, cancer cells also
exhibit demethylation of oncogenes during the development of cancer. For example, certain
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carcinogens, such as cigarette smoke extract (CSE) have the ability to downregulate the DNMT
isoform DNMT3B, which leads to demethylation of oncogenes (Liu et al., 2007). Recent studies
have shed light upon demethylating enzymes. The TET family of genes has specifically TET1,
TET2, and TET3 has been gaining increased attention because they demethylated mammalian
DNA (Tsumagari et al., 2013).
There are two different families of DNMTs, DNMT1, and 3. Figure 12 is a schematic of
DNMTs, DNMT1 is a maintenance enzyme that is responsible for maintaining methylation
patterns during chromosomal replication and repair by associating with replication sites by
directly binding to proliferating cell nuclear antigen. The newly synthesized strand of DNA now
contains the same DNA methylation pattern (Mortusewicz et al., 2005). DNMT1 has a 30-40
fold preference for hemimethylated sites (Cheng and Blumenthal, 2008). DNMT2 appears to
contain high sequence and structural similarity; however DNMT2 does not contain any DNA
methylating activity. DNMT2 methylates cytosine 38 in the anticodon loop of tRNA (Cheng and
Blumenthal, 2008). DNMT2 is also believed to be involved in the recognition of DNA damage,
DNA recombination and mutation repair and does not exhibit de novo or maintenance activity in
either embryonic stem cells, or adult somatic tissues (Turek-Plewa and Jagodzinski, 2005). The
DNMT3 family contains two active de novo DNMTs. De novo is a Latin expression meaning
"from the beginning" the DNMT3 family is able to methylate previously unmethylated CpG
sites. These de novo methyltransferases establish methylation patterns in embryonic stem cells.
In the DNMT3 family there are 3 different DNMTs; DNMT3A, DNMT3B, and DNMT3L.
DNMT3A and DNMT3B are both active de novo DNMTs, DNMT3-Like protein is a regulatory
factor (Cheng and Blumenthal, 2008). DNMT3L is known to be involved in maternal genomic
imprinting which affects the activity of DNMT3A and 3B, however DNMT3L does not seem to
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actively methylate DNA (Cheng and Blumenthal, 2008; Turek-Plewa and Jagodzinski, 2005).
Figure 12 displays the different DNMT domains, the conserved catalytic domains lead to activity
or lack of activity on DNA.

De novo methylation activity has been shown to be important to embryonic development.
DNMT3B knockout mice have multiple developmental defects. These defects include growth
impairment and rostral neural tube development. Okano et al. developed DNMT3B knockout
mice; none of these mice experienced a live birth. DNMT3A knockout mice also suffered major
developmental deficiencies. The DNMT3A mice were able to experience a live birth; however
they quickly became runted and died about 4 weeks after birth. DNMT 1 knockout mice were
also not viable (Okano et al., 1999).
In addition to playing a key role in the development of cancer, DNA methylation also
plays a key role in metabolic regulation in cells. DNA methylation in normal and cancer muscle
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cells is altered when exposed to butyrate, a short-chain fatty acid. Similarly, when muscle cells
were exposed to acute palmitate, or oleate increased promoter methylation was observed in the
mitochondrial protein peroxisome proliferator-activated receptor gamma coactivator 1 α
(PGC1α) (Barres et al., 2012). DNA methylation can modify the expression of PGC1α and
PPARγ, two transcription factors that are involved in fatty acid storage and glucose metabolism
(Barres et al., 2009). This suggests that cellular metabolism is epigenetically regulated by DNA
methylation, and may play an important role in cancer metabolism. Cancer cells exhibit an
altered basal metabolism. Normal cells produce energy via oxidative phosphorylation occurring
in the mitochondria, when starved of oxygen normal cells will produce energy via glycolysis.
Cancer cells are less dependent on the mitochondria pathway; instead cancer cells produce a
large portion of their ATP via glycolysis regardless of oxygen availability. This phenomenon of
altered metabolism was discovered in 1924 by Otto Warburg. Warburg's hypothesis regarding
the altered metabolism was that aerobic glycolysis was the primary energy source because
mitochondrial (respiratory) injury had occurred (Upadhyay et al., 2013; Warburg, 1956). During
glycolysis a large amount of lactic acid builds, creating a highly acidic local environment. Tumor
cells proliferate at a high rate in a vastly different environment, tumor cells prefer an acidic
environment; they also prefer hypoxic conditions. Micro-environments that lack sufficient
oxygen are said to be hypoxic. Hypoxia is associated with tumor progression, metastasis and
resistance to therapy (Upadhyay et al., 2013). HIF1α is a critical transcription factor associated
with hypoxic conditions, becoming highly upregulated in these conditions. HIF-1 activity has
been shown to promote tumor progression, while inhibition of HIF-1 could represent a novel
approach to cancer therapy (Semenza, 2002)
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Materials and Methods
Cell Culture:
C2C12 mouse myoblasts, HEK293T, and HEK293F human embryonic kidney cells, and
human lung adenocarcinoma cells (A549) were cultured under normal conditions prior to
treatments with compounds and siRNA. Normal culture conditions includes; Dulbecco’s
Modified Eagle Medium (DMEM) with the addition of 10% Fetal Bovine Serum (FBS), and 1%
penicillin/streptomycin, cells were grown in a 37 °C 5% CO2 incubator. For differentiation
experiments, C2C12 cells were plated at 1.5 x 105 cells per well, in a 6-well dish, or 5 x 105 cells
in a 10 cm plate, DMEM was supplemented with 2% HS, and 1% P/S. Media was changed every
other day for 5 days, after which the cells were either lysed, or treated with compounds.
siRNA:
siGENOME SMARTpool- DNMT3B siRNA (M-006395-01-0005), DNMT3A siRNA
(M-006672-03-0005), and DNMT1 (M004605-01-0005) were purchased from Dharmacon
(Thermo Fisher Scientific Waltham, MA). siGENOME Non-Targeting siRNA Pool #2 served as
a control (D-001206-14-05). siNT acts as our control because it is similar to the other siRNA’s,
however it does not target anywhere in the genome. The siRNA was received lyophilized, and;
they were reconstituted in RNase and nuclease-free water at a final concentration of 20 µM, and
stored at -80°C per manufacturer’s instructions.
siRNA Transfection:
A549 cells were plated on Day 0 at 3 x 105 cells per well in a 6-well dish in DMEM
supplemented with 10% FBS, without phenol red or antibiotics. The following day, cells were
transfected with 100nM siRNA, using DharmaFECT 1, as recommended by the manufacturer.
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After 48 hours, culture media were collected and stored at -80°C for future analysis. Cells were
incubated for an additional 24 hours before being harvested.
DNMT3A overexpression:
Addgene Plasmid 35521 was received as a stab cultures from Addgene (Cambridge,
MA). Vector constructs were produced in the Arthur Riggs laboratory (Chen et al., 2005).
Cultures were streaked onto LB agar plates + 100 µg/ml ampicillin (Amp). Single colonies were
selected and inoculated in 5 mL of 2X YT media + Amp, and placed in a 37°C shaking incubator
for 16 hours at 250 rpm. Plasmid DNA was isolated via Qiagen Plasmid Mini Kit. Plasmids were
sequenced by Eurofins US (Huntsville, AL) to confirm the identity of the construct. Large-scale
plasmid purification was accomplished with the Zyppy Plasmid Maxi-Prep Kit (Zymo
Scientific), (Irvine, CA) and all DNA was brought to a final concentration of 1 mg/ml.
DNMT3B Overexpression:
DNMT3B constructs were generated using Gateway cloning technology. DNMT3B-GFP was
generated by performing an LR Clonase reaction (Life Technologies) using pENTR223.1DNMT3B (Open Biosystems clone 40080753) and pcDNA-DEST47 (Life Technologies) to
produce a C-terminal GFP fusion construct driven by the human cytomegalovirus (CMV)
promoter. DNMT3B-HIS was generated by performing an LR Clonase reaction (Life
Technologies) using pENTR223.1-DNMT3B (Open Biosystems clone 40080753) and pcDNADEDT40 (Life Technologies) to produce a C-terminal 6XHIS/V5-fusion construct driven by the
CMV promoter. Bother constructs are shown below in Figure 13.
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Transfection:
A549 cells were plated on Day: 0 at 5*10^5 cells per well in a 6-well dish. 2µg of DNA
was incubated in 250µL of Opti-MEM Reduced Serum Media, Lipofectamine 2000 (Life
Technologies) was used 3:1 in excess, also incubated in 250µL Opti-MEM. The two components
incubated for 5 minutes at room temperature, then incubated together for 20 minutes. 1.5mL of
Opti-MEM was added directly onto cells, 500µL of DNA Lipofectamine 2000 was added
dropwise to each well. Cells were incubated for 16 hours, then DMEM +10%FBS +1%Pen/Strep
was added and incubated for an additional 24 hours.
RNA Collection:
Cells were collected via incubation with Trypsin + EDTA (0.25%) (MediaTech Inc.
Manassas, VA) for 4 minutes at 37°C, 5% CO2, and centrifuged at 1,500 rpm for 3 minutes.
Supernatant was removed and cells were snap-frozen on dry ice. Cell pellets were stored at -80°
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or processed immediately. Total RNA was extracted using Qiagen’s (Valencia, CA) RNeasy Plus
Mini Kit according to the manufacturer’s instructions.
Reverse Transcriptase PCR:
cDNA was synthesized from 0.5-1 µg of total RNA input using iScript Reverse
Transcription Supermix for RT-qPCR Bio-Rad (Hercules, CA. Reactions occurred in a T100
Thermal Cycler (Bio-Rad), following manufacturer’s instructions.
Real-Time Quantitative PCR:
Real-Time Quantitative PCR (RT-qPCR) was performed using a Bio-Rad CFX Connect
Real-Time PCR Detection System. Data acquisition was performed on Bio-Rad CFX Manager
3.0 software. Each 20 µl reaction was comprised of forward and reverse primers at a final
concentration of 500nM, 5 µl cDNA diluted five-fold, 3 µL water, and 10µl SsoAdvanced SYBR
Green Supermix (Bio-Rad).
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Protein Collection and Concentration Assay:
Cells were collected using trypsin, centrifuged for 3 minutes at 1,500 rpm at 4°C. Cells
were then lysed in 1X RIPA buffer containing 1X PhosSTOP (Roche Kaiseraugst, Switzerland),
and 1X Protease Inhibitor(Roche). Depending on the plate size the volume of RIPA buffer was
adjusted accordingly. Samples were subjected to 30 second sonication, and then centrifuged at
15,000 x g for 30-40 minutes at 4°C. A Bradford-Coomassie Assay (Pierce/ Thermo Fisher
Scientific) was performed to determine the concentration of total protein per sample.
Western Blot Analysis:
50-150µg of protein per sample was run on Invitrogen’s NuPAGE SDS-PAGE Gel
System using 1.0 mm 4-12% Bis-Tris precast gels in 1X MOPS running buffer following the
manufacturer’s instructions. Transfers were done following manufacturer’s instructions and
membranes were blocked for one hour at room temperature with 5% milk in 1XTBST.
PhosSTOP phosphate inhibitor cocktail(Roche) was added to the blocking buffer for membranes
that were to be probed with specific antibodies.
Antibodies:
Primary antibodies were purchased from Cell Signaling Technology (Boston, MA) unless
otherwise stated. They were used as instructed by manufacturer. Mouse anti DNMT3A antibody
was purchased from New England BioLabs Inc. (Ipswich, MA), used at a final concentration of
1:1,000. Antibodies were diluted in 5% non-fat dry milk in 1XTBST. 5% Sodium Azide (NaN3)
was added at a 1:100 dilution, To serve as a preservative. Secondary antibodies were purchased
from Cell Signaling Technology and GE Healthcare (Waukesha, WI), and diluted at 1:2,000 in
5% non-fat milk in 1XTBST.
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Immunoprecipitation:
Pierce A/G Magnetic beads were a generous gift by the Lunyak Lab. 500µl of sample
was combined with 5 µl of 1° antibody and incubated overnight at 4°C. Beads were washed, and
then incubated with sample for 5 hours. Samples were then heated for 10 minutes at 100°C. 20µl
of sample was then run on a 4-12% Bis-Tris precast gels in 1X MOPS running buffer per
manufacturers instructions.
Results and Discussion
DNMT3B Endogenous Protein Immunoprecipitation:
We began examining the de novo methyltransferase DNMT3B with great interest. The
two active de novo DNMT’s are of great interest because they are responsible for establishing
the pattern of methylation. This causes gene silencing, which is fundamental in cancer
development. However, methylation is not only important in cancer development. DNA
methylation also has also been shown to play a role in cellular metabolism and physiology.
Isolation of the protein would allow us to examine the crystal structure using mass spectrometry.
We first wanted to examine the DNMT3B protein to measure endogenous levels. We started by
conducting a western blot. Lane 2 and lane 3 are both control samples. DNMT3B has a
molecular weight of 96 kDa.
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The total amount of protein that was loaded into each well was approximately 180µg of
protein and the DNMT3B protein showed a very slight band pattern. After determining low
expression via western blot as shown in Figure 14, an immunoprecipitation was conducted. The
goal of immunoprecipitating the protein was to excise the band from the gel, and examine the
crystal structure of the band using mass spectrometry.
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After multiple trials of trying to immunoprecipitate the protein we were unable to see the
DNMT3B protein band. Two vector constructs were used in our attempt to immunoprecipitate
the protein. A DEST40 vector containing the DNMT3B protein fused to a 6x HIS tag, and a
DEST 47 vector containing the DNMT3B protein fused to GFP. The GFP was used as a
transfection control to ensure transfection efficiency. Unfortunately, 48 hours post transfection a
very small amount of GFP was present in the DEST 47 transfected cells. (data not shown)
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DNMT3B Overexpression Western Blot:

When we did not see the protein bands via immunoprecipitation we decided to ensure the
band could be seen once conducting a transient transfection and preforming a western blot.
Figure 16 shows that we were only able to detect a protein band in one lane, and at very minute
amounts. The results obtained from all western blot analyses, and immunoprecipitations
prompted moving from a normal cell, to a cancer cell.
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DNMT3B Endogenous Protein Expression in A549 Adenocarcinoma Cells

A549 lung adenocarcinoma cells are known to have higher expression levels of
DNMT3B. Western blot analysis confirmed, Figure 17 shows A549 cells grown in a 10-cm dish,
cells were collected and prepared. Each lane was loaded with 44µg of protein. Purifying the
DNMT3B protein proved more difficult than initially anticipated, therefore we decided to
examine an alternative method of protein manipulation. Overexpression of the DNMT3B protein
is still of great interest. Further optimizations of overexpression protocols are necessary.
siRNA Mediated Silencing of DNMT1, DNMT3A, DNMT3B
Using RNA interference (RNAi) to silence DNMT1, DNMT3A, and DNMT3B genes
allows us to study the effects of these genes, and their importance. To test the level of
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knockdown in samples qRT-PCR analysis was completed, the level of knockdown was
ascertained. As seen in Figure 18 knockdown efficiencies were successful, approximately 80%.

39

A549 Show Increased Sensitivity to Glycolytic and Mitochondrial Inhibitors when DNMT’s
are Knocked Down
Once the level of gene knockdown was confirmed, glycolytic and mitochondrial
inhibitors were tested to examine the role DNMTs play in regulating cellular metabolism,
specifically lung cancer metabolism. Cancer cell metabolism differs from non-meiotic cells in
ATP production. Cancer cells and other highly proliferative tissues acquire a large portion of
their energy from glycolysis, whereas non-meiotic cells produce large amounts of ATP via
oxidative phosphorylation in the mitochondria. This prompted examination of multiple metabolic
inhibitors. A549 cells were transiently transfected with 100nM siRNA for 48 hours, siRNA was
then removed and inhibitors were added. Figure 11 shows the effects of the different glycolytic
and mitochondrial inhibitors on ATP production levels. A CellTiter-Glo Assay (Promega
Madison, WI) measures ATP, which is representative of metabolically active cells. Normal
glucose containing media was used as a control for all samples. Galactose forces cells into
mitochondrial respiration because oxidation of galactose to pyruvate via glycolysis yields no net
ATP. (Marroquin et al., 2007). The next inhibitor used was 2-deoxyglucose, which is a glucose
analogue that competitively inhibits hexokinase activity in the first enzymatic step of glycolysis.
(Suchorolski et al., 2013) Bromo-pyruvate is also a hexokinase II inhibitor.(Nakano et al., 2011)
Oligomycin was the next inhibitor; oligomycin inhibits the mitochondrial ATP synthase. (Zhang
et al., 2012b) The final inhibitor used was rotenone, rotenone is a potent mitochondrial complex I
inhibitor. (Xiong et al., 2013) In figure 11 A549 cells were treated with siRNA for 48 hours, then
the media was changed and compounds were added. Upon addition of compounds all siRNA
mediated knockdown samples showed increased sensitivity towards glycolytic and mitochondrial
inhibitors.
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The altered basal metabolism cancer cells experience has been known for about 100
years. Otto Warburg’s hypothesis regarding cancer cells preference towards glycolysis is still a
mystery. Figure 19 shows A549 cells treated with siRNA, and then treated with compounds that
inhibit the glycolytic (2-DG, BP) or mitochondrial pathway (OL, ROT) cellular viability is
decreased dramatically. DNMT1 knock-down shows increased sensitivity, but cells are not quite
as inhibited by glycolytic inhibitors as DNMT3B knockdown samples. DNMT3B shows a
dramatic loss in viability when treated with glycolytic inhibitors, which shows DNMT3B could
be mediating glycolysis. Whether the effect is causal, or cooperative is unknown. DNMT3A
shows a similar trend towards sensitivity when treated with inhibitors, however the effect is less
dramatic when treated with 2-DG. Interestingly 2-DG and BP had differing results. 2-DG
showed a slight increase in sensitivity, where BP showed a very extreme sensitization.
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Oligomycin is a potent inhibitor of ATP synthase. Not surprisingly, oligomycin showed a very
dramatic effect in all the DNMT knockdown samples. Rotenone also displayed a similar effect.
Due to the large amount of sensitivity conveyed by the different inhibitors, we believe DNMT’s
are important for metabolism.
Global Analysis of Metabolites after DNMT Knockdown via HPLC-MS
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Figure 20 represents metabolites from the glycolytic pathway. DNMT1 knockdown
samples show a slightly reduced level of glycolytic intermediates, the changes seen are slight,
however they are statistically significant. The amount of lactic acid produced by DNMT1
knockdown is much higher than control samples. The DNMT3A knockdown samples show an
increase in a large portion of glycolytic intermediates, silencing of the DNMT3A gene shows an
upregulation in glycolysis. This is also confirmed by figure 21 showing a large increase in lactic
acid present. Glycolysis is a rapid way of producing ATP, a byproduct is lactic acid. Following a
similar trend as the DNMT1 knockdown, DNMT3B shows significantly altered metabolites, both
up and down regulated. The extracellular fingerprinting of lactic acid on DNMT3B media
confirms that lactic acid production is slightly less than control samples. The most dramatic
difference in glycolysis was seen in the DNMT3A knockdown samples.
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The pentose phosphate pathway (PPP) is important for two main reasons, one is the production
of ribose-5-phosphate (R5P), which is used for the synthesis of nucleotides, and also the
formation of NADPH which protects against oxidative stress. NADPH neutralizes reactive
oxygen intermediates. (Perl et al., 2011) In figure 22 we can see that DNMT1, and DNMT3B
have similar patterns of metabolites, this was also seen in the glycolytic pathway. Metabolites
from the pathway are significantly up and down regulated. These data points suggest that
DNMT1 and DNMT3B enzymes have similar characteristics in metabolism. DNMT3A shows a
different pattern. DNMT3A shows a very strong trend towards upregulation of metabolites and
intermediate products.
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Figure 23 represents metabolites in the tricarboxylic acid (TCA) cycle, also known as
Krebs cycle. The TCA cycle is the major final common pathway for oxidation of carbohydrates,
lipids, and some amino acids, resulting in large amounts of ATP via oxidative phosphorylation.
Fluctuation of the TCA cycle directly affects oxidative phosphorylation. (Bowtell et al., 2007)
Figure 23 shows intermediate metabolites of the TCA cycle. In this pathway all DNMT’s seem
to have a slightly different affect. The DNMT1 knockdown samples are all slightly increased, the
most dramatic increase being 2-hydroxygluterate, and malic acid. DNMT3A knockdown samples
a very noticeably increased in all metabolites and intermediate products. DNMT3B shows a
small amount of decrease in some metabolites, of all the conditions DNMT3B seems to have to
smallest effect in the TCA cycle.
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Figures: 20, 21, 22, 23 show global metabolite changes after treatment with siRNA. The amount
of metabolites and intermediates that are both increased and decreased show that all DNMT’s
play a role in cellular metabolism. DNMT3A knockdown seems to have the most significant
effect in all pathways. DNMT3A knockdown samples seem to increase all metabolites in
glycolysis, PPP, and TCA cycle. These three cycles differ in many respects, which lead us to
believe that DNMT3A is very significantly involved in cellular metabolism. Analysis of these
pathways and transcription factors that could be involved in the metabolism changes prompts
investigation into energy signaling.
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Transcription Factors Involved in DNMT Mediated Metabolism:

PPARγ is a member of the nuclear hormone receptor suerfamily. PPARγ is associated
with sensing fatty acids, and other nutritional signals (Semple et al., 2006). DNMT1 silencing
does not seem to alter the expression level of PPARγ, however DNMT3A, and DNMT3B seem
to have differential effects on PPARγ expression levels. DNMT3A causes a 2-fold increase,
where DNMT3B causes almost a 1.5 fold decrease in expression level.
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PGC1α is a key transcriptional regulator of lipogenesis and oxidative metabolism.
PGC1α has been implicated in cancer development, however different sources have reported
opposing results. Initially lower PGC1α expression was associated with cancerous tissue.
Conversely, PGC1α expression has been shown in cancer cell proliferation. (Bhalla et al., 2011)
Figure X represents the expression level of PGC1α. Both DNMT1, and DNMT3A knockdown
samples show elevated PGC1α levels. In contrast DNMT3B samples show a large decrease in
expression.
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Hypoxic-Inducible factor 1α (HIF-1α) is a transcription factor that mediates adaptive
responses to reduced O2 availability, including angiogenesis and glycolysis. Expression of HIF1α increases dramatically when cells are hypoxic. DNMT1, and DNMT3B knockdown does not
seem to alter the level of HIF-1α, DNMT3A knockdown seems to have a large effect on HIF-1α
expression.
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Conclusions:

Figures 24, 25, 26 show expression level of samples; promoter methylation status is not
taken into account. Promoter methylation analysis is the next step. The data collected thus far
shows that DNMT1 is important in metabolism and silencing the gene causes global metabolism
changes. DNMT3B is also important in metabolism. DNMT3B is also important in regulating
transcription factors associated with metabolic homeostasis. DNMT3A seems to have the most
dramatic effect in metabolism. DNMT3A knockdown samples showed a more ideal environment
for cancer cell proliferation. The lactic acid increase, increased sensitivity to both glycolytic and
mitochondrial inhibitors, and the high induction of HIF1α all suggest that DNMT3A is playing a
significant role in cancer metabolism. As previously mentioned promoter methylation status is
the next step in determining what genes are being expressed. Enzymatic activity assay kits that
measure DNMT activity are also available. Determining DNMTs exact mechanism in the context
of cancer cell metabolism will ideally shed light on the Warburg Effect.
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